NASDAQ:SOMX - Pernix Sleep Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Pernix Sleep logoPernix Sleep Inc, formerly Somaxon Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of branded products and late-stage product candidates. The Company operates in one segment, which is the development and commercialization of pharmaceutical products. The Company's focus is on commercial activities relating to Silenor. As of December 31, 2011, the clinical development program for Silenor included four Phase III clinical trials. In June 2011, it entered into agreements with Paladin Labs Inc. (Paladin), under which Paladin had the right to commercialize Silenor in Canada, South America, the Caribbean and Africa, subject to the receipt of marketing approval in each such territory. In March 2013, Pernix Therapeutics Holdings Inc acquired the Company.

Receive SOMX News and Ratings via Email

Sign-up to receive the latest news and ratings for SOMX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A
Market Cap$0.00

Pernix Sleep (NASDAQ:SOMX) Frequently Asked Questions

What is Pernix Sleep's stock symbol?

Pernix Sleep trades on the NASDAQ under the ticker symbol "SOMX."

Has Pernix Sleep been receiving favorable news coverage?

News coverage about SOMX stock has been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Pernix Sleep earned a news and rumor sentiment score of 0.16 on Accern's scale. They also assigned headlines about the specialty pharmaceutical company an impact score of 47.89 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future. View Recent Headlines for Pernix Sleep.

How do I buy shares of Pernix Sleep?

Shares of SOMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Pernix Sleep?

Pernix Sleep's mailing address is 440 Stevens Ave Ste 200, SOLANA BEACH, CA 92075-2059, United States. The specialty pharmaceutical company can be reached via phone at +1-302-6587581.

MarketBeat Community Rating for Pernix Sleep (NASDAQ SOMX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  66 (Vote Underperform)
Total Votes:  136
MarketBeat's community ratings are surveys of what our community members think about Pernix Sleep and other stocks. Vote "Outperform" if you believe SOMX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SOMX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel